Lumos Diagnostics Revenue and Competitors

Sarasota,

Location

$15M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Lumos Diagnostics's estimated annual revenue is currently $5M per year.(i)
  • Lumos Diagnostics's estimated revenue per employee is $77,500
  • Lumos Diagnostics's total funding is $15M.

Employee Data

  • Lumos Diagnostics has 65 Employees.(i)
  • Lumos Diagnostics grew their employee count by -21% last year.

Lumos Diagnostics's People

NameTitleEmail/Phone
1
SVP, Commercial OperationsReveal Email/Phone
2
VP, Corporate Marketing & CommunicationsReveal Email/Phone
3
VP, Quality and Regulatory AffairsReveal Email/Phone
4
Director Manufacturing and Manufacturing TransferReveal Email/Phone
5
Technology Transfer Scientist DirectorReveal Email/Phone
6
Director US SalesReveal Email/Phone
7
Sr. Director FP&AReveal Email/Phone
8
Sr. Director, Medical Affairs (Head Medical Affairs)Reveal Email/Phone
9
Chief Financial OfficerReveal Email/Phone
10
Chief Technology OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Lumos Diagnostics?

Lumos Diagnostics delivers custom diagnostic solutions by combining deep market insight with existing platform technologies, assay development capability and regulated manufacturing experience. We have built a truly unique business that, for the first time, combines all the elements you need for a complete point-of-care (POC) solution. Our team is focussed purely on creating custom POC diagnostic testing platforms, leveraging our existing technologies where appropriate. By using existing Lumos technologies, we accelerate the time to market and de-risk product development, reducing the cost of customization. Lumos Diagnostics - for custom design and manufacture of POC testing platforms: - All elements of POC development needed in-house - Over 30 years' experience in POC test development - Wide range of existing product designs to choose from, but can also customize to specific customer requirements.

keywords:N/A

$15M

Total Funding

65

Number of Employees

$5M

Revenue (est)

-21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Lumos Diagnostics News

2021-07-08 - Lumos Diagnostics : Raises $63M AUD in ASX IPO

Rapid, point-of-care (POC) diagnostics company, Lumos Diagnostics, today announced it has been admitted to the Australian Securities Exchange (ASX) with trading commencing on July 5 after raising $63 million AUD in an Initial Public Offering (IPO). Lumos is a fully integrated developer and manuf ...

2021-04-06 - DIASORIN S.P.A. DiaSorin S p A : announces its strategic collaboration with Lumos Diagnostics

DIASORIN IS COLLABORATING WITH LUMOS DIAGNOSTICS TO LAUNCH THE LIAISON® IQ, A NEW IMMUNOASSAY POINT-OF-CARE PLATFORM, AND THE FIRST TWO ASSAYS FOR DECENTRALIZED COVID-19 TESTING DIASORIN ANNOUNCES ITS STRATEGIC COLLABORATION WITH LUMOS DIAGNOSTICS, A POINT-OF-CARE(POC) DIAGNOSTIC SPECIALIST TO ...

2020-10-07 - Lumos Diagnostics Raises AU$25M in Pre-IPO Funding

Lumos Diagnostics, a Melbourne, Australia-based rapid point-of-care diagnostics company, closed an AU$25m pre-IPO funding, ahead of an anticipated 2021 Australian Securities Exchange (ASX) listing. The capital was raised from a combination of institutional funds, including Perennial Value and E ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.8M65-2%N/A
#2
$14.7M653%N/A
#3
$13.9M66-15%N/A
#4
$5.9M66-12%N/A
#5
$8.6M6657%N/A